These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF. Hashemi J; Lindström MS; Asker C; Platz A; Hansson J; Wiman KG Cancer Lett; 2002 Jun; 180(2):211-21. PubMed ID: 12175554 [TBL] [Abstract][Full Text] [Related]
27. Combined analysis of p53 and RB pathways in epithelial ovarian cancer. Hashiguchi Y; Tsuda H; Yamamoto K; Inoue T; Ishiko O; Ogita S Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230 [TBL] [Abstract][Full Text] [Related]
28. The Han M; Yamaguchi S; Onishi M; Fujii T; Hosoya M; Wen X; Kido H; Kato S Anticancer Res; 2022 May; 42(5):2277-2288. PubMed ID: 35489754 [TBL] [Abstract][Full Text] [Related]
29. MDM2 overexpression is associated with short survival in adults with medulloblastoma. Giordana MT; Duó D; Gasverde S; Trevisan E; Boghi A; Morra I; Pradotto L; Mauro A; Chió A Neuro Oncol; 2002 Apr; 4(2):115-22. PubMed ID: 11916503 [TBL] [Abstract][Full Text] [Related]
30. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303 [TBL] [Abstract][Full Text] [Related]
31. [Interactive pathway of ARF-mdm2-p53]. Lin J; Zhu MH Ai Zheng; 2003 Mar; 22(3):328-30. PubMed ID: 12654198 [TBL] [Abstract][Full Text] [Related]
32. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998 [TBL] [Abstract][Full Text] [Related]
33. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071 [TBL] [Abstract][Full Text] [Related]
34. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Cobbers JM; Wolter M; Reifenberger J; Ring GU; Jessen F; An HX; Niederacher D; Schmidt EE; Ichimura K; Floeth F; Kirsch L; Borchard F; Louis DN; Collins VP; Reifenberger G Brain Pathol; 1998 Apr; 8(2):263-76. PubMed ID: 9546285 [TBL] [Abstract][Full Text] [Related]
35. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
36. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Lerman DM; Monument MJ; McIlvaine E; Liu XQ; Huang D; Monovich L; Beeler N; Gorlick RG; Marina NM; Womer RB; Bridge JA; Krailo MD; Randall RL; Lessnick SL; Pediatr Blood Cancer; 2015 May; 62(5):759-65. PubMed ID: 25464386 [TBL] [Abstract][Full Text] [Related]
37. Detection and Correlation of Single and Concomitant Pessôa IA; Amorim CK; Ferreira WAS; Sagica F; Brito JR; Othman M; Meyer B; Liehr T; de Oliveira EHC Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151164 [TBL] [Abstract][Full Text] [Related]
38. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Lindström MS; Klangby U; Wiman KG Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201 [TBL] [Abstract][Full Text] [Related]
39. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas. Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti MA; Severini A Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212 [TBL] [Abstract][Full Text] [Related]
40. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]